ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 235 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q2 2015. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $851,000 | +70.9% | 58,912 | -3.6% | 0.01% | +40.0% |
| Q3 2020 | $498,000 | +20.6% | 61,142 | +0.2% | 0.01% | +25.0% |
| Q2 2020 | $413,000 | -32.1% | 61,026 | -29.3% | 0.01% | -42.9% |
| Q1 2020 | $608,000 | -28.3% | 86,361 | 0.0% | 0.01% | -17.6% |
| Q4 2019 | $848,000 | -11.7% | 86,361 | -1.2% | 0.02% | -15.0% |
| Q3 2019 | $960,000 | -7.0% | 87,396 | -1.5% | 0.02% | -9.1% |
| Q2 2019 | $1,032,000 | +18.8% | 88,715 | -2.6% | 0.02% | +22.2% |
| Q1 2019 | $869,000 | -1.5% | 91,110 | -0.4% | 0.02% | -18.2% |
| Q4 2018 | $882,000 | -31.0% | 91,516 | +2.0% | 0.02% | -18.5% |
| Q3 2018 | $1,278,000 | +16.7% | 89,681 | -1.7% | 0.03% | +8.0% |
| Q2 2018 | $1,095,000 | -2.4% | 91,269 | +0.5% | 0.02% | -3.8% |
| Q1 2018 | $1,122,000 | -13.4% | 90,835 | +2.0% | 0.03% | -13.3% |
| Q4 2017 | $1,295,000 | +1.5% | 89,015 | -0.7% | 0.03% | -3.2% |
| Q3 2017 | $1,276,000 | +12.8% | 89,644 | +1.1% | 0.03% | +10.7% |
| Q2 2017 | $1,131,000 | +4.6% | 88,646 | +4.0% | 0.03% | 0.0% |
| Q1 2017 | $1,081,000 | +22.6% | 85,277 | -1.3% | 0.03% | +16.7% |
| Q4 2016 | $882,000 | -22.4% | 86,385 | +0.1% | 0.02% | -25.0% |
| Q3 2016 | $1,137,000 | +5.0% | 86,318 | +1.2% | 0.03% | 0.0% |
| Q2 2016 | $1,083,000 | -0.6% | 85,311 | +3.5% | 0.03% | -3.0% |
| Q1 2016 | $1,089,000 | -10.6% | 82,440 | +4.1% | 0.03% | -13.2% |
| Q4 2015 | $1,218,000 | +26.5% | 79,168 | +1.9% | 0.04% | +18.8% |
| Q3 2015 | $963,000 | +2.1% | 77,686 | +12.7% | 0.03% | +10.3% |
| Q2 2015 | $943,000 | +15.4% | 68,914 | +0.8% | 0.03% | +16.0% |
| Q1 2015 | $817,000 | -13.0% | 68,343 | -7.0% | 0.02% | +257.1% |
| Q4 2014 | $939,000 | -5.4% | 73,495 | -0.7% | 0.01% | -12.5% |
| Q3 2014 | $993,000 | -11.1% | 74,044 | +6.4% | 0.01% | -11.1% |
| Q2 2014 | $1,117,000 | -2.4% | 69,621 | +9.7% | 0.01% | 0.0% |
| Q1 2014 | $1,144,000 | +17.7% | 63,447 | +0.9% | 0.01% | +12.5% |
| Q4 2013 | $972,000 | +3.7% | 62,904 | -0.1% | 0.01% | -27.3% |
| Q3 2013 | $937,000 | +4.2% | 62,990 | -9.3% | 0.01% | +10.0% |
| Q2 2013 | $899,000 | – | 69,440 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 1,375,000 | $20,006,000 | 10.92% |
| Adirondack Research & Management Inc. | 574,033 | $8,352,000 | 3.28% |
| GLENHILL ADVISORS LLC | 2,461,034 | $35,808,000 | 2.64% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 1,949,600 | $28,367,000 | 2.42% |
| DALTON GREINER HARTMAN MAHER & CO | 2,990,902 | $43,518,000 | 2.28% |
| S&T BANK/PA | 703,223 | $10,231,000 | 1.73% |
| Tibra Equities Europe Ltd | 263,344 | $3,832,000 | 1.64% |
| Millrace Asset Group, Inc. | 116,675 | $1,697,000 | 1.63% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 1,271,450 | $18,502,000 | 1.31% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,423,223 | $137,108,000 | 1.15% |